A clinical scoring tool 0-4 for the severity of AN predictive of IR

  • Research type

    Research Study

  • Full title

    To establish whether the severity of insulin resistance and risk of Type 2 Diabetes is effectively indicted by the corresponding score for the severity score of Acanthosis Nigricans of the skin

  • IRAS ID

    272268

  • Contact name

    Neil Wright

  • Contact email

    neil.wright1@nhs.net

  • Sponsor organisation

    Sheffield Children's Hospital NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    0 years, 5 months, 24 days

  • Research summary

    Acanthosis Nigricans (AN) is a dark brown velvety discolouration of the skin typically on the back of the neck and in the armpit. It is thought to be caused by high levels of insulin in the blood and is strongly associated with Type 2 Diabetes and with obesity. Insulin is a hormone in your body that controls your blood sugar, levels of insulin can become too high if the body is unable to respond how to It should to insulin. Whilst not all individuals with obesity and Type 2 Diabetes have Acanthosis, those individuals with Acanthosis have almost double the risk of Type 2 Diabetes compared to those who do not.
    Acanthosis is therefore a highly visible risk marker for Type 2 Diabetes. As such it may be an appropriate area in which to consider whether a public health campaign or self-assessment tool may help identify previously undetected cases of Type 2 Diabetes and identify individuals at higher risk of Type 2 Diabetes in whom early interventions may prevent progression to Diabetes.
    The development of the clinical scoring tool to be validated has been in development through the previous streams of research involved in this research study.
    Participants will consist of child participants aged 11-18 years of age with AN. It is intended that 60-70 participants will be recruited. Participants will attend an appointment whereby: AN severity will be recorded; blood tests will be performed; risk factors for type 2 diabetes will be recorded. This appointment will last no longer than 1 hour.

  • REC name

    East of England - Cambridge East Research Ethics Committee

  • REC reference

    20/EE/0023

  • Date of REC Opinion

    19 Feb 2020

  • REC opinion

    Further Information Unfavourable Opinion